#USA #Nashville #Petauri #Elisa Boyle #Michelle Jacobson

Petauri Expands Leadership Team for Enhanced Market Access

Petauri, a dedicated pharmaceutical services platform, is ramping up its market presence with significant leadership changes designed to strengthen its capabilities in providing comprehensive value and access solutions throughout the healthcare sector. On July 23, 2026, the company officially introduced Elisa Boyle as Senior Vice President of Client Engagement and welcomed Michelle Jacobson as Senior Director of Value and Access, marking a pivotal evolution in its Advisors leadership team.

Strategic Leadership Appointments

Elisa Boyle, who has been a part of Petauri since its inception, brings nearly two decades of invaluable experience from her time working with various pharmaceutical manufacturers. Her promotion signifies Petauri’s intent to not only solidify existing client relationships but also foster new partnerships that can drive strategic initiatives forward. Elisa’s focus will be on establishing connections with executive-level clients and guiding them through the complexities of market access.

Dan Vanderpoel, PharmD and President of Petauri Advisors, commented, "Elisa's transition to this pivotal role reflects a strategic investment in our clients and our future growth. With her acute understanding of industry challenges, she's adept at transforming these into meaningful growth opportunities. She will play a crucial part in shaping the market access strategies early in the product lifecycle."

On the other hand, Michelle Jacobson joins with an impressive background of over 25 years, having previously held the position of Senior Director of Trade Client Strategy at Prime Therapeutics. Her expertise spans various therapeutic areas, enabling her to drive payer engagement in specialty markets such as rare diseases and HIV. In her new role, Michelle will enhance the Access Customer Experience (ACE) team and work towards crafting effective solutions that bridge clinical, financial, and operational perspectives. Her knowledge in developing value-based contracts and engaging government programs is poised to bolster Petauri’s overall mission.

Commitment to Integrated Solutions

The recent steps Petauri has taken are anchored in a broader commitment to establishing itself as a powerhouse in market access within the pharmaceutical industry. The company's focus lies in unifying various expert capabilities across payer, manufacturer, provider, and commercialization viewpoints. As the landscape for value and access continues to evolve, Petauri is positioned to aid life sciences companies in anticipating shifts, devising evidence-based tactics, and facilitating improved access to groundbreaking therapies.

Elisa and Michelle's leadership roles are part of a larger strategy underlined by Petauri's mission: to maximize patient outcomes by clearly demonstrating the scientific, economic, humanistic, and societal value of medical advancements.

About Petauri

Founded in Nashville, Tennessee, Petauri was established by CEO Dan Renick in partnership with Oak Hill Capital, aimed at merging and acquiring industry-leading firms recognized for their expertise in global market access, medical affairs, and patient services. Since its launch in 2023, Petauri has significantly expanded its reach and capabilities, now comprising six operational units under the Petauri umbrella.

With ongoing financial and structural investments, including anticipated contributions exceeding $250 million from Oak Hill, Petauri is committed to supporting its pharmaceutical clients in navigating the intricacies of market access. The ultimate goal is to accelerate patients' access to life-enhancing care while continuously enhancing their operational capabilities.

For further insights, visit Petauri's official website. Whether it's through strategic implementation or hands-on client engagement, Petauri is eager to lead the charge in connecting innovators with patients who could benefit from their advancements.